Clinical Trial Update: Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating imatinib (Glivec) in patients with adenoid cystic carcinoma of the head and neck; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma of the Head and Neck

Drugs mentioned

• Imatinib (Glivec) (imatinib)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Cancer of the Head and Neck, Carcinoma, Adenoid Cystic | Phase 2 | Status: UNKNOWN